The entries of “Technologies made in Vienna” are displayed in the project language.
Technologies from Vienna
Vivaldi Biosciences AG
Certain infectious and parasitic diseasesVivaldi AG was formed to rapidly advance the clinical development of a new-generation influenza vaccine to address the urgent, unmet need for a safer and more effective pediatric influenza vaccine.
deltaFLU is based on a novel method of attenuation and unique mode of action of that confer cross-reactivity and cross-protection against variant influenza strains, key attributes of a long-sought universal influenza vaccine, which has the potential to transform the influenza vaccine market.
Kontakt Wirtschaftsagentur Wien
The “Fit for the Future” project is co-financed by the European Regional Development Fund and contributes to the development of applied research and innovation activities in Vienna, promoting cooperation and inspiring young people in Vienna to explore research and innovation. Further information can be found under the IGJ/ERDF funding programme.